ArticleJAMA cardiology2020
Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter?
Article in JAMA cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmas.ESC heart failure · 2022Pooled it
- Low ALT levels and a new diagnosis of congestive heart failure following COVID-19 infection.Frontiers in cardiovascular medicine · 2025Article
- RNA-Seq analysis of human heart tissue reveals SARS-CoV-2 infection and inappropriate activation of the TNF-NF-κB pathway in cardiomyocytes.Scientific reports · 2024Article
- Article
- Effects of COVID-19 on the Autonomic Cardiovascular System: Heart Rate Variability and Turbulence in Recovered Patients.Texas Heart Institute journal · 2023Article
- Major adverse cardiovascular events are associated with necroptosis during severe COVID-19.Critical care (London, England) · 2023Observational
- Necroptosis Drives Major Adverse Cardiovascular Events During Severe COVID-19.Research square · 2023Article
- Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response.PLoS biology · 2022Article
- Myocarditis in the Athlete: A Focus on COVID-19 Sequelae.Clinics in sports medicine · 2022Review
- Trends of Myocarditis and Endocarditis Cases before, during, and after the First Complete COVID-19-Related Lockdown in 2020 in France.Biomedicines · 2022Article
- Hippo Signaling Pathway Activation during SARS-CoV-2 Infection Contributes to Host Antiviral Response.bioRxiv : the preprint server for biology · 2022Article
- Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives.BMC medical ethics · 2022Review
- The Additive Value of Cardiovascular Magnetic Resonance in Convalescent COVID-19 Patients.Frontiers in cardiovascular medicine · 2022Review
- Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America.Journal of cardiac failure · 2022Article
- Post-Acute Sequelae of SARS-COVID-2 Syndrome: Just the Beginning.Cardiology research · 2021Review
- Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin.International journal of cardiology · 2021Article
- Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study.Biomedicines · 2021Article
- Does hydroxychloroquine still have any role in the COVID-19 pandemic?Expert opinion on pharmacotherapy · 2021Article
- A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome-A Pilot Study.Journal of clinical medicine · 2021Article
- Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32730614What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.